Abstract LB-219: ApoE and its' receptors (LRP8, VLDLR) function as growth signals for triple-negative breast cancer and represents novel therapeutic targetsChristine Y. Shiang, Lajos Pusztai, Yuan Qi et al.|Cancer Research|2011Cited by 3